Quantcast
Last updated on April 24, 2014 at 12:40 EDT

Latest Mitral regurgitation Stories

2011-04-05 00:26:08

Measuring oxidative stress may help doctors predict the risk of developing atrial fibrillation, the most common heart beat irregularity. Research from Emory University School of Medicine has identified a connection between oxidative stress and enlargement of the heart's left atrium, which leads to atrial fibrillation. The data is being presented on Monday, April 4, by Emory cardiology researcher Nima Ghasemzadeh, MD, at the American College of Cardiology meeting in New Orleans. Working with...

2011-04-04 08:00:00

NorthShore University HealthSystem's Ted Feldman, MD, Presents Late Breaking Data at American College of Cardiology Conference EMBARGOED FOR RELEASE UNTIL 8 AM, CDT, APRIL 4, 2011 EVANSTON, Ill., April 4, 2011 /PRNewswire-USNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy), that were concurrently published in The New England Journal...

2011-04-04 08:00:00

NEW ORLEANS, April 4, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in...

2011-04-01 00:14:17

NYU Langone Medical Center surgeons are performing minimally invasive heart surgery techniques on patients in their 80s and 90s. Outcomes are strong, going against the assumption that elderly patients who have heart surgery are destined to a steady decline. New York, NY (Vocus/PRWEB) March 31, 2011 NYU Langone Medical Center has performed minimally invasive heart surgery for over 15 years. In that time there has been an increase in elderly patients. Now 5% of the surgeries are performed on...

2011-03-30 08:00:00

ABBOTT PARK, Ill., March 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's catheter-based MitraClip® system for the treatment of mitral regurgitation (MR) in Australia. The MitraClip device, which has received Therapeutic Goods Administration (TGA) approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition. Chronic, severe MR is often associated with heart failure and can result in...

2011-01-18 06:45:00

Cardiac Surgery Market to Reach Over $4.4 Billion by 2017 VANCOUVER, Jan. 18 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017. Adoption of these devices for treating mitral regurgitation,...

2010-09-21 11:53:22

A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation, according to a study presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. Mitral valve regurgitation is one of the most common forms of heart disease. The study was led by James Hermiller, MD, Director of Cardiovascular Intervention at the...

2010-08-18 05:00:00

KIRKLAND, Wash., Aug. 18 /PRNewswire/ -- Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN(TM) trial of the Company's CARILLON® Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress (ESC) on August 29, 2010 in Stockholm. Professor Dr. Uta Hoppe of...

2010-05-25 06:30:00

PARIS, May 25 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced new data from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial, which provide additional details about the safety and clinical benefit of Abbott's investigational MitraClip® system for the two causes of mitral regurgitation (MR) - functional MR (FMR) or degenerative MR (DMR). In the EVEREST II trial, the 30-day major adverse event rate in the MitraClip arm was similar...

2010-05-06 13:00:00

SAN DIEGO, May 6 /PRNewswire/ -- An innovative catheter-based procedure is providing relief to patients who suffer from shortness of breath and fluid overload as the result of a severely leaky heart valve, but who are too sick for open-chest surgery, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions. Data from the Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II) High Risk Registry showed...